These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38982944)

  • 1. In silico evidence of bitopertin's broad interactions within the SLC6 transporter family.
    de Carvalho GA; Tambwe PM; Nascimento LRC; Campos BKP; Chiareli RA; Junior GPN; Menegatti R; Gomez RS; Pinto MCX
    J Pharm Pharmacol; 2024 Sep; 76(9):1199-1211. PubMed ID: 38982944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of glycine transporters: From molecules to behavior.
    Marques BL; Oliveira-Lima OC; Carvalho GA; de Almeida Chiarelli R; Ribeiro RI; Parreira RC; da Madeira Freitas EM; Resende RR; Klempin F; Ulrich H; Gomez RS; Pinto MCX
    Neurosci Biobehav Rev; 2020 Nov; 118():97-110. PubMed ID: 32712279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2.
    Erdem FA; Ilic M; Koppensteiner P; Gołacki J; Lubec G; Freissmuth M; Sandtner W
    J Gen Physiol; 2019 Aug; 151(8):1035-1050. PubMed ID: 31270129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient.
    Pinard E; Borroni E; Koerner A; Umbricht D; Alberati D
    Chimia (Aarau); 2018 Aug; 72(7):477-484. PubMed ID: 30158010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers.
    Hofmann C; Pizzagalli F; Boetsch C; Alberati D; Ereshefsky L; Jhee S; Patat A; Boutouyrie-Dumont B; Martin-Facklam M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2429-39. PubMed ID: 27178435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the inhibition of glycine reuptake.
    Shahsavar A; Stohler P; Bourenkov G; Zimmermann I; Siegrist M; Guba W; Pinard E; Sinning S; Seeger MA; Schneider TR; Dawson RJP; Nissen P
    Nature; 2021 Mar; 591(7851):677-681. PubMed ID: 33658720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GlyT1 determines the glycinergic phenotype of amacrine cells in the mouse retina.
    Eulenburg V; Knop G; Sedmak T; Schuster S; Hauf K; Schneider J; Feigenspan A; Joachimsthaler A; Brandstätter JH
    Brain Struct Funct; 2018 Sep; 223(7):3251-3266. PubMed ID: 29808289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.
    Jiménez E; Núñez E; Ibáñez I; Zafra F; Aragón C; Giménez C
    Neuropharmacology; 2015 Feb; 89():245-54. PubMed ID: 25301276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin and evolution of vertebrate glycine transporters.
    Shpak M; Gentil LG; Miranda M
    J Mol Evol; 2014 Apr; 78(3-4):188-93. PubMed ID: 24619162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers.
    Martin-Facklam M; Pizzagalli F; Zhou Y; Ostrowitzki S; Raymont V; Brašić JR; Parkar N; Umbricht D; Dannals RF; Goldwater R; Wong DF
    Neuropsychopharmacology; 2013 Feb; 38(3):504-12. PubMed ID: 23132267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aspartate residue in the external vestibule of GLYT2 (glycine transporter 2) controls cation access and transport coupling.
    Pérez-Siles G; Núñez E; Morreale A; Jiménez E; Leo-Macías A; Pita G; Cherubino F; Sangaletti R; Bossi E; Ortíz AR; Aragón C; López-Corcuera B
    Biochem J; 2012 Mar; 442(2):323-34. PubMed ID: 22132725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain.
    Schlösser L; Barthel F; Brandenburger T; Neumann E; Bauer I; Eulenburg V; Werdehausen R; Hermanns H
    Neurosci Lett; 2015 Jul; 600():213-9. PubMed ID: 26101830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) Inhibitor.
    Barrow P; Parrott N; Alberati D; Paehler A; Koerner A
    Birth Defects Res B Dev Reprod Toxicol; 2016 Jun; 107(3):148-56. PubMed ID: 27221585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.
    Eddins D; Hamill TG; Puri V; Cannon CE; Vivian JA; Sanabria-Bohórquez SM; Cook JJ; Morrow JA; Thomson F; Uslaner JM
    Psychopharmacology (Berl); 2014 Feb; 231(3):511-9. PubMed ID: 24051602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional 'glial' GLYT1 glycine transporters expressed in neurons.
    Raiteri L; Raiteri M
    J Neurochem; 2010 Aug; 114(3):647-53. PubMed ID: 20477934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodents.
    Deiana S; Hauber W; Munster A; Sommer S; Ferger B; Marti A; Schmid B; Dorner-Ciossek C; Rosenbrock H
    Eur J Pharmacol; 2022 Nov; 935():175306. PubMed ID: 36183855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics.
    Mostyn SN; Wilson KA; Schumann-Gillett A; Frangos ZJ; Shimmon S; Rawling T; Ryan RM; O'Mara ML; Vandenberg RJ
    Elife; 2019 Oct; 8():. PubMed ID: 31621581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2.
    Carland JE; Thomas M; Mostyn SN; Subramanian N; O'Mara ML; Ryan RM; Vandenberg RJ
    ACS Chem Neurosci; 2018 Mar; 9(3):603-614. PubMed ID: 29120604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACS chemical neuroscience molecule spotlight on RG1678.
    Hopkins CR
    ACS Chem Neurosci; 2011 Dec; 2(12):685-6. PubMed ID: 22860161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.